Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by CAMILO JIMENEZ and NANCY DUGAL PERRIER.
CAMILO JIMENEZ
Connection Strength
3.567
NANCY DUGAL PERRIER
  1. SDHB-Associated Pheochromocytomas: What is Their Clinical Behavior? Ann Surg Oncol. 2024 Dec; 31(13):9007-9013.
    View in: PubMed
    Score: 0.248
  2. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma. J Clin Endocrinol Metab. 2023 04 13; 108(5):1132-1142.
    View in: PubMed
    Score: 0.223
  3. Pheochromocytoma recurrence in hereditary disease: does a cortical-sparing technique increase recurrence rate? Surgery. 2023 Jan; 173(1):26-34.
    View in: PubMed
    Score: 0.216
  4. American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary. JAMA Surg. 2022 10 01; 157(10):870-877.
    View in: PubMed
    Score: 0.215
  5. Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome. Surgery. 2022 08; 172(2):559-566.
    View in: PubMed
    Score: 0.209
  6. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma. Pancreas. 2021 04 01; 50(4):469-493.
    View in: PubMed
    Score: 0.194
  7. Impact of surgical resection for subdiaphragmatic paragangliomas. World J Surg. 2014 Mar; 38(3):733-41.
    View in: PubMed
    Score: 0.119
  8. Long-term outcomes of surgical treatment for hereditary pheochromocytoma. J Am Coll Surg. 2013 Feb; 216(2):280-9.
    View in: PubMed
    Score: 0.110
  9. Robotic-assisted retroperitoneoscopic adrenalectomy: making a good procedure even better. Am Surg. 2013 Jan; 79(1):84-9.
    View in: PubMed
    Score: 0.110
  10. Greater than age-predicted functional deficits in older patients with primary hyperparathyroidism. Endocr Pract. 2012 Jul-Aug; 18(4):450-5.
    View in: PubMed
    Score: 0.106
  11. Preoperative serum osteocalcin may predict postoperative elevated parathyroid hormone in patients with primary hyperparathyroidism. World J Surg. 2012 Jun; 36(6):1320-6.
    View in: PubMed
    Score: 0.105
  12. Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience. Cancer. 2012 Jun 01; 118(11):2804-12.
    View in: PubMed
    Score: 0.101
  13. Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. Surgery. 2011 Sep; 150(3):452-8.
    View in: PubMed
    Score: 0.100
  14. Posterior retroperitoneoscopic adrenalectomy: a contemporary American experience. J Am Coll Surg. 2011 Apr; 212(4):659-65; discussion 665-7.
    View in: PubMed
    Score: 0.097
  15. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011 Mar; 96(3):717-25.
    View in: PubMed
    Score: 0.095
  16. Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized control trial. Ann Surg. 2010 May; 251(5):832-7.
    View in: PubMed
    Score: 0.091
  17. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2010 May; 95(5):2023-37.
    View in: PubMed
    Score: 0.090
  18. Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome. Nat Rev Endocrinol. 2010 Feb; 6(2):110-5.
    View in: PubMed
    Score: 0.089
  19. Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism. World J Surg. 2009 Nov; 33(11):2292-302.
    View in: PubMed
    Score: 0.088
  20. Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. Surgery. 2009 Dec; 146(6):1116-22.
    View in: PubMed
    Score: 0.088
  21. Outpatient minimally invasive parathyroidectomy is safe for elderly patients. J Am Coll Surg. 2009 Jun; 208(6):1071-6.
    View in: PubMed
    Score: 0.085
  22. A novel nomenclature to classify parathyroid adenomas. World J Surg. 2009 Mar; 33(3):412-6.
    View in: PubMed
    Score: 0.084
  23. Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery. 2008 Dec; 144(6):852-8; discussion 858-9.
    View in: PubMed
    Score: 0.083
  24. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab. 2009 Feb; 94(2):386-91.
    View in: PubMed
    Score: 0.082
  25. Posterior retroperitoneoscopic adrenalectomy: preferred technique for removal of benign tumors and isolated metastases. Ann Surg. 2008 Oct; 248(4):666-74.
    View in: PubMed
    Score: 0.082
  26. Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer Registry. Endocr Pract. 2024 Jan; 30(1):25-30.
    View in: PubMed
    Score: 0.058
  27. Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience. J Clin Endocrinol Metab. 2022 04 19; 107(5):1239-1246.
    View in: PubMed
    Score: 0.052
  28. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head Neck. 2020 06; 42(6):1325-1328.
    View in: PubMed
    Score: 0.046
  29. Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. J Immunother Cancer. 2019 09 18; 7(1):253.
    View in: PubMed
    Score: 0.044
  30. Genetic profiling as a clinical tool in advanced parathyroid carcinoma. J Cancer Res Clin Oncol. 2019 Aug; 145(8):1977-1986.
    View in: PubMed
    Score: 0.043
  31. Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma. Ann Surg. 2018 07; 268(1):172-178.
    View in: PubMed
    Score: 0.040
  32. Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. Ann Surg Oncol. 2018 May; 25(5):1395-1402.
    View in: PubMed
    Score: 0.039
  33. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. Thyroid. 2014 Jul; 24(7):1096-106.
    View in: PubMed
    Score: 0.030
  34. Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing?s syndrome. Surgery. 2013 Dec; 154(6):1174-83; discussion 1183-4.
    View in: PubMed
    Score: 0.029
  35. A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. J Clin Endocrinol Metab. 2013 Jan; 98(1):192-7.
    View in: PubMed
    Score: 0.027
  36. Metastatic pheochromocytoma and paraganglioma: focus on therapeutics. Horm Metab Res. 2012 May; 44(5):390-9.
    View in: PubMed
    Score: 0.026
  37. Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nat Rev Endocrinol. 2011 Aug 23; 7(10):596-607.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.